FindTrial
Sign In

Intelligent solution for prenatal diagnosis of fetal intrauterine development abnormalities

Intelligent solution for prenatal diagnosis of fetal intrauterine development abnormalities

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000037573
Enrollment
Unknown
Registered
2020-08-28
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fetal intrauterine development is mainly manifested by fetal long bone development abnormality

Interventions

fetal&#32
intrauterine&#32
development&#32
abnormalities
Gold Standard:Clinical outcome
Index test:Prenatal&#32
intelligent&#32
diagnosis&#32
model&#32
of&#32

Sponsors

The International Peace Maternity & Child Health Hospital of China welfare institute (IPMCH)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: All fetuses examined by ultrasound during the second trimester included both single and twin live fetuses

Exclusion criteria

Exclusion criteria: Nil

Design outcomes

Primary

MeasureTime frame
SEN, SPE, ACC, AUC of ROC, NPV, PPV;—

Countries

China

Contacts

Public ContactYanlin Wang

The International Peace Maternity & Child Health Hospital of China welfare institute (IPMCH)

wyanlin@163.com+86 21 8017316123

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026